Healthy volunteers test new capsule for nervous system disorders
Knowledge-focused
Completed
This early-stage study tested the safety of a new capsule called glyceryl tribenzoate (GTB) in 40 healthy adults aged 18 to 50. Participants received either a single or multiple doses to see how the body processes the drug and if any side effects occur. The goal was not to treat …
Phase: PHASE1 • Sponsor: Forest Hills Lab • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC